Shares of International Stem Cell Co. (OTCMKTS:ISCO – Get Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.10 and traded as high as $0.10. International Stem Cell shares last traded at $0.10, with a volume of 200 shares traded.
International Stem Cell Stock Performance
The firm has a market cap of $800,000.00, a P/E ratio of -3.33 and a beta of 0.50. The business’s 50-day simple moving average is $0.09 and its 200 day simple moving average is $0.10.
International Stem Cell (OTCMKTS:ISCO – Get Free Report) last issued its quarterly earnings data on Thursday, March 28th. The biotechnology company reported ($0.04) EPS for the quarter. International Stem Cell had a negative return on equity of 2.80% and a negative net margin of 2.68%. The firm had revenue of $1.89 million during the quarter.
International Stem Cell Company Profile
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Read More
- Five stocks we like better than International Stem Cell
- What Are Dividend Challengers?
- Roblox: The Bottom Just Fell Out of the Metaverse
- Stock Analyst Ratings and Canadian Analyst Ratings
- Airbnb Stock Plummets After Earnings, But is It a Buy?
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Uber’s Earnings Drop Is Investors Opportunity
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
